-
-
-
Laboratory findings (Patient 1) Detecting Item (Normal range) Feb 8 Feb 21 Feb 26 Mar 2 Mar 3 Mar 4 Mar 7 Mar 9 Mar 11 Mar 14 White blood cell count (×109/L) (3.50–9.50) ND 6.3 5.0 ND 6.9 ND 4.3 ND ND 7.8 Neutrophil count (×109/L) (1.80–6.30) ND 4.47 2.98 ND 4.70 ND 2.78 ND ND 5.42 Lymphocyte count (×109/L) (1.10–3.20) ND 1.08 1.16 ND 1.20 ND 0.70 ND ND 1.31 C-reactive protein (mg/L) (0.00–5.00) ND 39.71 ND ND ND ND 1.56 ND ND 0.29 Red blood cell count (×1012/L) (4.3–5.8) ND 4.07 3.98 ND 3.77 ND 4.01 ND ND 4.02 Urea (mmol/L) (1.8–7.3) ND 1.97 1.55 ND ND ND 1.95 ND 2.94 3.61 Creatinine (µmol/L) (44–97) ND 70.7 59.2 ND ND ND 63.0 ND 74.3 31.7 Uric acid (mmol/L) (3.1–8) ND 217 164 ND ND ND 230 ND 285 231 IL-6 (pg/mL) (< 7) ND ND ND 30.54 ND ND ND 688.40 ND 521 SARS-CoV-2 IgM (< 10) ND ND ND ND ND 30.12 ND ND ND 0.96 SARS-CoV-2 IgG (< 10) ND ND ND ND ND 63.52 ND ND ND 3.87 SARS-CoV-2 nucleic acid test + ND ND ND ND ND ND ND ND ND Co-infection detection HIV(0-1) ND ND ND ND ND ND ND ND 69.63 ND Syphilis(0-1) ND ND ND ND ND ND ND ND 8.74 ND Hepatitis B ND ND ND ND ND ND ND ND − ND Hepatitis C ND ND ND ND ND ND ND ND − ND Notes: ND, no data; +, positive; -, negative Table 1. Laboratory findings of patient 1 co-infected with SARS-CoV-2 and HIV
-
Detecting Item (Normal range) Result (%) Leukocyte differential count (Parient 1) Lymphocyte count (20%–40%) 13.1 Monocyte count (3%–8%) 7.2 Granulocyte count (50%–70%) 79.6 CD3+ (59%–85%) 77.6 CD3+CD4+ (Male, 29%–57%) 1.0 CD3+CD8+ (11%–38%) 72.7 CD3+CD4+/CD3+CD8+ (0.9–3.6) 0.01 CD3-CD19+ (6.4%–23%) 12.9 CD3-(CD16+/CD56+) (5.6%–31%) 4.7 Table 2. Leukocyte differential count and Lymphocyte subpopulation
-
Laboratory findings (Patient 2) Detecting Item (Normal range) Feb 11 Feb 16 Feb 20 Feb 22 Feb 25 Feb 26 Feb 29 Mar 1 Mar 2 Mar 3 Mar 5 Mar 6 White blood cell count (×109/L) (3.50–9.50) 4.2 3.2 4.6 3.8 ND 4.6 4.8 3.3 ND ND ND ND Neutrophil count (×109/L)
(1.80–6.30)1.97 2.18 3.16 2.38 ND 2.70 2.80 2.23 ND ND ND ND Lymphocyte count (×109/L) (1.10–3.20) 1.55 0.60 0.91 0.84 ND 1.30 1.34 0.56 ND ND ND ND C-reactive protein (mg/L) (0.00–5.00) 96.51 42.70 26.06 11.14 ND 6.89 6.78 11.65 ND ND ND ND Red blood cell count (×1012/L) (4.3–5.8) 4.99 4.85 5.28 4.67 ND 5.06 5.04 4.52 ND ND ND ND Urea (mmol/L) (1.8–7.3) 6.21 ND 4.63 6.00 ND ND 4.91 3.56 ND ND ND ND Creatinine (µmol/L) (44–97) 92.0 ND 64.6 71.7 ND ND 64.4 63.2 ND ND ND ND Uric acid (mmol/L) (3.1–8) 286 ND 236 292 ND ND 321 299 ND ND ND ND IL-6 (pg/mL) (< 7) ND ND ND ND ND ND ND ND 9.87 ND ND 141.40 SARS-CoV-2 IgM (< 10) ND ND ND ND ND ND ND ND ND ND 0.79 0.86 SARS-CoV-2 IgG (< 10) ND ND ND ND ND ND ND ND ND ND 0.63 0.57 SARS-CoV-2 nucleic acid test − ND +* ND − ND − ND ND − ND ND Co-infection detection HIV (0-1) ND ND ND ND ND ND ND ND ND ND ND 58.3 Syphilis (0-1) ND ND ND ND ND ND ND ND ND ND ND 11.67 Hepatitis B ND ND ND ND ND ND ND ND − ND ND ND Hepatitis C ND ND ND ND ND ND ND ND − ND ND ND Notes: ND, no data; +*, single positive; -, negative Table 3. Laboratory findings of patient 2 co-infected with SARS-CoV-2 and HIV
Figure 2 个
Table 3 个
